品牌簡介

Matriks Biotek® Co., as a biotechnology company founded in 2002 and is celebrating its 15 years in the business. Production oriented company is committed to R&D and innovation of immune based, molecules and tools that will help well being. On the market with biological drug testing SHIKARI® ELISA kits for 10 years since first produced and commercialized in the whole world market. In 36 countries and over 30 pharmaceutical companies have used and/or using our products with confidence. The use of biologics, mainly humanized recombinant monoclonal antibodies, in certain diseases as pharmaceutical drugs elicits the question of effectiveness in each individually treated person. Monitoring drug levels and antibodies plays an emerging role in the management of lack- or loss of response to recombinant and/or humanized antibodies (i.e., to confirm treatment continuation, adjustment to dose, provide a rationale for switching to another agent or to a different class of biological agent).